LETTER
Synthesis of Spirocyclic Pyrido[1,2-a]indole Derivatives
3357
(3) (a) Gross, S.; Reissig, H.-U. Org. Lett. 2003, 5, 4305.
(b) Hiroi, K.; Hiratsuka, Y.; Watanabe, K.; Abe, I.; Kato, F.;
Hiror, M. Tetrahedron: Asymmetry 2002, 13, 1351.
(c) Teuber, H. J.; Worbs, E.; Cornelius, D. Arch. Pharm.
1982, 315, 388. (d) Ozaki, S.; Mitoh, S.; Ohmori, H. Chem.
Pharm. Bull. 1996, 44, 2020.
(4) Gribble, G. W. J. Chem. Soc., Perkin Trans. 1 2000, 1045.
(5) Bytschkov, I.; Siebeneicher, H.; Doye, S. Eur. J. Org. Chem.
2003, 2888.
(6) Nicolaou, K. C.; Roecker, A. J.; Hughes, R.; Summeren, R.
V.; Pfefferkorn, J. A.; Winssinger, N. Bioorg. Med. Chem.
2003, 11, 465.
(7) Closson, W. D.; Roman, S. A.; Kwiatkowski, G. T.; Corwin,
D. A. Tetrahedron Lett. 1966, 21, 2271.
104.4, 64.3, 38.4, 26.6, 22.5, 15.4, 12.1. GC–MS (tR = 19.96
min): m/z = 225 (56) [M+], 197 (100), 154 (48), 115 (13).
HRMS (FAB): m/z [M + H+] calcd for C15H16ON: 226.1232;
found: 226.1216.
5b: The general procedure was followed with the use of
substrate 4b (0.68 g) and product 5b (0.97 g, 81%) was
obtained as a orange-brown solid after purification. 1H NMR
(500 MHz, CDCl3): d = 7.18 (d, J = 8.2 Hz, 1 H), 7.10 (t,
J = 7.5 Hz, 1 H), 6.88 (t, J = 7.4 Hz, 1 H), 6.69 (d, J = 7.4
Hz, 1 H), 4.30 (dd, J = 4.0, 16.4 Hz, 1 H), 2.50 (s, 3 H), 2.47
(t, J = 16.1 Hz, 1 H), 2.18 (dd, J = 3.9, 15.9 Hz, 1 H), 1.86
(s, 3 H), 1.21–1.27 (m, 2 H), 0.90–0.93 (m, 1 H), 0.73–0.76
(m, 1 H). 13C NMR (125 MHz, CDCl3): d = 191.7, 153.8,
143.8, 137.8, 127.1, 121.8, 119.3, 111.9, 111.1, 64.0, 39.2,
29.9, 18.7, 14.9, 13.4, 10.6. GC–MS (tR = 20.02 min): m/z =
239 (100) [M+], 211 (90), 196 (20), 182 (35), 168 (88), 129
(18), 115 (29). HRMS (FAB): m/z [M + H+] calcd for
C16H18ON: 240.1388; found: 240.1388.
(8) Johansen, J. E.; Christie, B. D.; Rapoport, H. J. Org. Chem.
1981, 46, 4914.
(9) Amombo, M. O.; Hausherr, A.; Reissig, H.-U. Synlett 1999,
1871.
(10) (a) Clive, D. L. J.; Wang, J.; Yu, M. Tetrahedron Lett. 2005,
46, 2853. (b) Rubiralta, M.; Diez, A.; Vila, C.; Troin, Y.;
Feliz, M. J. Org. Chem. 1991, 56, 6292.
5c: The general procedure was followed with the use of
substrate 4c (0.97 g) and product 5c (1.09 g, 76%) was
obtained as a brown-black solid after purification. 1H NMR
(500 MHz, CDCl3): d = 7.50–7.52 (m, 5 H), 6.79 (td, J = 1.0,
7.4 Hz, 1 H), 6.73 (td, J = 1.4, 7.5 Hz, 1 H), 6.65 (dd, J = 1.0,
7.3 Hz, 1 H), 5.71 (d, J = 8.2 Hz, 1 H), 5.38 (s, 1 H), 4.65
(dd, J = 4.0, 15.9 Hz, 1 H), 2.75 (t, J = 16.1 Hz, 1 H), 2.24
(dd, J = 4.0, 16.3 Hz, 1 H), 1.19–1.22 (m, 2 H), 1.08–1.12
(m, 1 H), 0.88–0.91 (m, 1 H). 13C NMR (125 MHz, CDCl3):
d = 192.4, 157.8, 145.1, 139.5, 135.7, 131.1, 128.0, 127.1,
122.6, 118.5, 116.2, 114.9, 108.8, 66.3, 39.9, 27.0, 16.0,
13.8. GC–MS (tR = 24.35 min): m/z = 287 (81) [M+], 258
(100), 230 (85), 154 (26), 129 (45). HRMS (FAB): m/z [M +
H+] calcd for C20H18ON: 288.1388; found: 288.1390.
5d: The general procedure was followed with the use of
substrate 4d (0.70 g) and product 5d (0.75 g, 66%) was
obtained as a yellow solid after purification. 1H NMR (500
MHz, CDCl3; enol–keto mixture): d = 8.15 (d, J = 8.0 Hz, 0.4
H), 7.20 (t, J = 7.5 Hz, 0.6 H), 7.06 (t, J = 7.4 Hz, 0.5 H),
6.97 (td, J = 1.0, 7.6 Hz, 0.9 H), 6.69 (d, J = 7.6 Hz, 0.6 H),
6.65 (t, J = 7.3 Hz, 0.8 H), 6.56 (t, J = 7.0 Hz, 1.6 H), 5.28
(s, 0.1 H), 4.67 (m, 0.5 H), 4.11 (m, 1 H), 3.73 (s, 3.5 H), 2.73
(m, 1 H), 2.51–2.59 (m, 2 H), 1.22–1.39 (m, 3 H), 0.79–1.03
(m, 6.5 H). 13C NMR (125 MHz, CDCl3): d = 202.5, 167.3,
150.0, 133.3, 127.5, 127.0, 125.0, 118.8, 118.5, 116.0,
108.9, 59.8, 58.8, 52.5, 49.9, 49.5, 46.7, 42.3, 30.2, 28.0,
15.9, 15.5, 14.6, 12.2. GC–MS (tR = 19.26 min): m/z = 227
(35) [M+], 199 (82), 130 (100), 115 (48). HRMS (FAB):
m/z [M + H+] calcd for C14H14O2N: 228.1025; found:
228.1013.
(11) Huckin, S. N.; Weiler, L. J. Am. Chem. Soc. 1974, 96, 1082.
(12) General Procedure for Reaction Protocol: NaH (12 mmol,
0.29 g) was weighed out with a flask in a dry box and then
THF (40 mL) was added. The flask was placed in an ice bath.
The mixture was stirred and 1,3-diketones or 1,3-ketoesters
4 (6 mmol) in THF (5 mL) was added dropwise into the
flask. The mixture was further stirred for 10 min at 0 °C and
then n-BuLi (12 mmol, 7.6 mL of 1.6 M n-BuLi solution in
hexane) was added dropwise. After 20 min, 3-(2-bromo-
ethyl) indole (5 mmol, 1.12 g) in THF (5 mL) was added
dropwise with stirring. The reaction mixture was warmed to
r.t. slowly and further stirred overnight. The reaction mixture
was hydrolyzed with 1% HCl solution (30 mL) and extracted
with Et2O. The combined organic extracts were washed with
H2O and dried over MgSO4. After filtration, the crude
product was concentrated and purified with column
chromatography. The obtained pure products 5 were
characterized with 500 MHz NMR, GC–MS, and HRMS.
(13) The NMR spectra were recorded with 500 MHz NMR
spectrometer. GC–MS method: initial temperature: 50 °C
(hold for 3 min), rate: 15 °C/min, final temperature: 280 °C
(hold for 7 min). Compound 5a: The general procedure was
followed with the use of substrate 4a (0.6 g) and product 5a
(0.95g, 85%) was obtained as a brown solid after
purification. 1H NMR (500 MHz, CDCl3): d = 7.21 (d, J =
8.2 Hz, 1 H), 7.12 (t, J = 7.3 Hz, 1 H), 6.94 (t, J = 7.4 Hz, 1
H), 6.72 (d, J = 7.2 Hz, 1 H), 5.19 (s, 1 H), 4.41 (dd, J = 4.1,
16.5 Hz, 1 H), 2.47 (s, 3 H), 2.42 (t, J = 16.2 Hz, 1 H), 2.14
(dd, J = 4.0, 15.8 Hz, 1 H), 1.22–1.29 (m, 2 H), 0.90–0.95
(m, 1 H), 0.71–0.76 (m, 1 H). 13C NMR (125 MHz, CDCl3):
d = 191.5, 156.7, 143.1, 137.8, 127.2, 122.9, 119.5, 112.3,
(14) (a) Revuelta, J.; Cicchi, S.; Brandi, A. J. Org. Chem. 2005,
70, 5636. (b) Cicchi, S.; Revuelta, J.; Zanobini, A.; Betti,
M.; Brandi, A. Synlett 2003, 2305.
Synlett 2006, No. 19, 3355–3357 © Thieme Stuttgart · New York